The clinical management of hepatocellular carcinoma in China: Progress and challenges

• Published in: Clinical and molecular hepatology Vol. 29; no. 2; pp. 339 - 341
• Main Authors: Shan, Shan, Jia, Jidong
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Association for the Study of the Liver 01.04.2023; The Korean Association for the Study of the Liver
• Subjects: Carcinoma, Hepatocellular - diagnosis; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - therapy; China - epidemiology; East Asian People; guideline; Hepatitis B; hepatocellular carcinoma; Humans; Immunotherapy; Liver cancer; Liver Neoplasms - pathology; Liver Neoplasms - therapy; Medical screening; Preventive medicine; treatment; China; Guideline; Hepatocellular carcinoma; Treatment
• ISSN: 2287-2728; 2287-285X; 2287-285X
• DOI: 10.3350/cmh.2023.0077

[...]the University of California San Francisco criteria for liver transplant are adopted and offer HCC patients more transplant opportunities than the Milan criteria but yield a similar post-transplant outcome. [...]this article also discussed multimodal and high-intensity anti-tumor strategies for HCC patients in real-life practices in China, such as the addition of immunotherapy-based systemic therapy to local modalities, which may improve the chance of receiving curative therapy and long-term survival for patients with nonearly-stage HCC. [...]due to poor adherence to long-term HCC surveillance [15], most patients with HCC are in intermediate or advanced stage, which carries a very poor survival rate since such patients are not eligible for curative therapy [16]. [...]the timely updating and advocating of evidence-based HCC guidelines will help improve the quality of care in real-world practice to improve clinical outcomes of HCC patients in China.